(a) whether the Government has taken any steps/ proposes to take steps for the promotion and development of indigenously manufactured drugs and medicines; and
(b) if so, the details thereof;
(a) whether the Government has taken any steps/ proposes to take steps for the promotion and development of indigenously manufactured drugs and medicines; and
(b) if so, the details thereof;
MINISTER OF STATE IN THE MINISTRY OF CHEMICALS & FERTILIZERS
(SHRI BHAGWANTH KHUBA)
(a) to (b): The Indian Pharmaceutical industry is the 3rd largest in the world by volume. India exported pharmaceuticals worth Rs. 1,80,551 crore in the financial year 2020-21. India exported Bulk Drugs/ Drug Intermediates worth Rs. 32,857 crore in financial year 2020-21.
The Government strives for promotion and development of indigenously manufactured drugs and medicines and to give fillip to indigenous manufacturing.
• In order to make the country Atmanirbhar in pharmaceuticals, the Department of Pharmaceuticals has launched the Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India. The total financial outlay of the scheme is Rs. 6,940 crore and the tenure from FY 2020-2021 to FY 2029-30. 49 projects with investment of Rs. 3685.38 crore have already been approved.
• Another Production Linked Incentive Scheme for Pharmaceuticals has been launched with total financial outlay of Rs. 15,000 crore and tenure from FY 2020- 2021 to FY 2028-29. The scheme intends to enhance India’s manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector. Approval has been granted to 55 companies under this scheme. The eligible drugs under this scheme include APIs among other categories of pharmaceutical products.
• The Department has launched a scheme to provide further support to API pharma companies through providing financial assistance to the States for establishing three Bulk Drug Parks.
• Further, Department provides support to the pharma clusters for creating common infrastructure facilities under Assistance to Pharmaceutical Industry for Common Facilities (API-CF).
• Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) has also been approved to support SME units in pharmaceutical sector for quality and technology upgradation.
*****